Hepatitis Clinical Trials: Active Studies by Market and Country

Clinical studies that are recruiting or active now, for each of our markets on this topic.

Source: ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, worldwide. Retrieved 12 Nov 2026.

Active trials by market

Studies that are recruiting, active, or about to start. One study can count for more than one market, so the numbers are not added up.

  1. 1Liver Cancer1,475Liver Cancer: See them on ClinicalTrials.gov (opens in a new tab)
  2. 2Liver Cirrhosis615Liver Cirrhosis: See them on ClinicalTrials.gov (opens in a new tab)
  3. 3Hepatitis Diagnostics501Hepatitis Diagnostics: See them on ClinicalTrials.gov (opens in a new tab)
  4. 4Hepatitis B293Hepatitis B: See them on ClinicalTrials.gov (opens in a new tab)
  5. 5Hepatitis B Treatment293Hepatitis B Treatment: See them on ClinicalTrials.gov (opens in a new tab)
  6. 6Hepatitis C102Hepatitis C: See them on ClinicalTrials.gov (opens in a new tab)
  7. 7Hepatitis E8Hepatitis E: See them on ClinicalTrials.gov (opens in a new tab)
  8. 8Hepatitis B Birth Dose Vaccination1Hepatitis B Birth Dose Vaccination: See them on ClinicalTrials.gov (opens in a new tab)

Source: ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, worldwide. Retrieved 12 Nov 2026.

Recently updated trials

Each opens its own record on ClinicalTrials.gov.

Source: ClinicalTrials.gov, Study records, newest update first. Retrieved 12 Nov 2026.

Benchmarks on hepatitis

Countries side by side on public measures for this topic.

All benchmarks

Acuitas market sizes and forecasts are only in our full reports. How we use public data.